Prelude Therapeutics

NASDAQ: PRLD · Real-Time Price · USD
1.02
0.04 (4.27%)
At close: Jun 06, 2025, 3:59 PM
1.03
0.98%
After-hours: Jun 06, 2025, 04:04 PM EDT

Prelude Therapeutics Revenue

Prelude Therapeutics reported an annual revenue of $7M, reflecting a 0% growth. For the quarter ending March 31, 2025, Prelude Therapeutics generated $0 in revenue.
Revenue (ttm)
$7M
Revenue Growth
0%
Price / Sales Ratio
13.75
Revenue / Employee
$53.44K
Employees
131
Market Cap
57.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.